| Study |
Reference |
|
Bànhidy, 2011
|
Banhidy Peptic ulcer disease with related drug treatment in pregnant women and congenital abnormalities in their offspring. Congenit Anom (Kyoto) 2011; 51:26-33
|
|
Choi, 2023
|
Choi Maternal Proton Pump Inhibitor Use During Pregnancy and Risk of Low Birth Weight in Offspring in Korea, 2008-2019. JAMA Netw Open 2023; 6:e237962
|
|
Diav-Citrin, 2005
|
Diav-Citrin The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment. Pharmacol. Ther. 2005; 21:269-75
|
|
Källén, 2001
|
Kallen Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001; 96:63-8
|
|
Källén, 2003
|
Källén Maternal drug use in early pregnancy and infant cardiovascular defect Reproductive Toxicology 2003; 17:255-.
|
|
Källèn (Controls exposed to other treatment, sick), 1998
|
Källén Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. Br J Obstet Gynaecol 1998; 105:877-81
|
|
Kerr, 2018
|
Kerr Risk factors for congenital microcephaly in the pre-Zika era. Birth Defects Res 2019; 111:96-118
|
|
Lalkin (Controls exposed to other treatment, sick), 1998
|
Lalkin The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am. J. Obstet. Gynecol. 1998; 179:727-30
|
|
Lalkin (Controls unexposed NOS), 1998
|
Lalkin The safety of omeprazole during pregnancy: A multicenter prospective controlled study Am. J. Obstet. Gynecol 1998;179:727-30
|
|
Lind, 2013
|
Lind Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007. Pharmacoepidemiol Drug Saf 2013; 22:783-93
|
|
Matok, 2012
|
Matok The safety of fetal exposure to proton-pump inhibitors during pregnancy. Dig. Dis. Sci. 2012; 57:699-705
|
|
Moretti, 2001
|
Moretti (cited by Nikfar 2002) Use of proton pump inhibitors during pregnancy and rates of major malformations (Personal communication). 2002
|
|
Pasternak, 2010
|
Pasternak Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N. Engl. J. Med. 2010; 363:2114-23
|
|
Ruigomez (Controls exposed to other treatment, sick), 1999
|
Ruigomez Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am. J. Epidemiol. 1999; 150:476-81
|
|
Ruigomez (Controls unexposed NOS), 1999
|
Ruigomez Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am. J. Epidemiol. 1999; 150:476-81
|
|
Van Gelder, 2022
|
Van Gelder Associations Between Late-Onset Preeclampsia and the Use of Calcium-Based Antacids and Proton Pump Inhibitors During Pregnancy: A Prospective Cohort Study. Clin Epidemiol 2022; 14:1229-1240
|
